The expression of CTSE in the present study was not significantly different between BLCA and controls, which may be related to the fact that a greater proportion of patients in the TCGA dataset with T3- 4 stage, so more experiments are needed to verify the effect of CTSE in BLCA tumorigenesis and progression. The gene discussed is CTSE; the disease is bladder transitional cell carcinoma.